NCT05829486

Brief Summary

Various complications are the leading cause of morbidity in sedation practices in endoscopic procedures, and guidelines recommend continuous monitoring of circulation, respiratory function, and ventilation. Integrated Pulmonary Index (IPI), one of the methods that can be used in this monitoring, gives a single numerical value obtained by continuous and simultaneous joint mathematical analysis of Oxygen saturation, End-tidal carbon dioxide concentration, respiratory rate, and heart rate values and is a good monitorization in these interventions. and provides tracking. In this study, the aim is to determine the role of IPI in the diagnosis and follow-up of respiratory complications in patients who were sedated during gastroscopy procedures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 6, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 31, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 25, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2023

Completed
Last Updated

August 22, 2023

Status Verified

August 1, 2023

Enrollment Period

8 months

First QC Date

March 31, 2023

Last Update Submit

August 21, 2023

Conditions

Keywords

sedationrespiratory complicationsambulatory anesthesia

Outcome Measures

Primary Outcomes (1)

  • respiratory complications comparing different sedative groups

    Comparison of sedation safety and efficacy of Ketamine and Propofol and Remifentanil and Propofol administration to be applied to patients in endoscopy by using integrated pulmonary index (1-10)

    Measurements will be in 4 time frames; before induction anesthesia, 5 minutes after the induction of sedation, 10 minutes after the induction, 5 minutes after the end of the procedure

Study Arms (2)

ketaprop

At the beginning of anesthesia, 0.25 mg/kg ketamine and 0.75 mg/kg propofol will be administered.

Procedure: gastroscopy

remiprop

At the beginning of anesthesia, 1 mcg/kg of remifentanil and 0.75 mg/kg propofol will be administered.

Procedure: gastroscopy

Interventions

gastroscopyPROCEDURE

anaesthetic management of ambulatory endoscopic procedures

ketapropremiprop

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

over the age of 18 who will undergo endoscopic intervention

You may qualify if:

  • ASA 1-2-3 risk scored patients,
  • patients over the age of 18 who will undergo endoscopic intervention

You may not qualify if:

  • Patients who need mechanical ventilator support,
  • patients who need emergency endoscopic intervention,
  • patients with a history of substance abuse,
  • patients with a history of allergy to the drugs to be used,
  • pregnant women will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziosmanpaşa TREH

Istanbul, Gaziosmanpaşa, 34255, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Gastroscopy

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • zuhal çavuş, MD

    gaziosmanpasa TREH

    PRINCIPAL INVESTIGATOR
  • döndü genç moralar, MD

    gaziosmanpasa TREH

    STUDY DIRECTOR

Central Study Contacts

sibel bektas, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
4 Months
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor, principal investigator

Study Record Dates

First Submitted

March 31, 2023

First Posted

April 25, 2023

Study Start

February 6, 2023

Primary Completion

September 30, 2023

Study Completion

November 5, 2023

Last Updated

August 22, 2023

Record last verified: 2023-08

Locations